X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-13 | NBIX | Onyia Jude | Chief Scientific Officer | S - Sale+OE | $132.94 | -1,432 | 13,128 | -10% | -$190,371 | |||||
2024-01-31 | NBIX | Onyia Jude | Chief Scientific Officer | S - Sale | $141.94 | -126 | 11,843 | -1% | -$17,884 | ||||||
2023-11-29 | NBIX | Onyia Jude | Chief Scientific Officer | S - Sale | $113.57 | -2,331 | 11,732 | -17% | -$264,733 | ||||||
2023-08-21 | NBIX | Onyia Jude | Chief Scientific Officer | S - Sale | $107.37 | -3,198 | 9,638 | -25% | -$343,368 | ||||||
2023-02-07 | NBIX | Onyia Jude | Chief Scientific Officer | S - Sale | $102.30 | -4,508 | 6,525 | -41% | -$461,166 | ||||||
2023-01-31 | NBIX | Onyia Jude | Chief Scientific Officer | S - Sale | $108.48 | -126 | 2,477 | -5% | -$13,668 | ||||||
2022-11-29 | NBIX | Onyia Jude | Chief Scientific Officer | S - Sale | $121.91 | -2,331 | 2,366 | -50% | -$284,160 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |